Sanofi, a French pharmaceutical giant, has increased its dividend payouts for 31 consecutive years, demonstrating consistent shareholder returns. The company grew its revenue from €34.7 billion in 2016 to €43.6 billion in 2025, with a steady compound annual growth rate of 2.6%. Sanofi maintains a strong financial position with a low long-term debt/equity ratio of 0.2 and a high interest coverage ratio of 11, indicating solid debt management. This sustained growth and financial stability make Sanofi a notable player in the pharmaceutical sector despite not being listed in the S&P 500 as a dividend aristocrat due to its non-American status.
Sanofi shares show steady interest on Pluang, trading at USD 41.81 with a 1-day gain of 0.50% and a dividend yield of 5.82%. The stock's market cap stands at $99.64 billion as of Oct 26, 2026 20:42 WIB.
